FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2938221794> ?p ?o ?g. }

• W2938221794 abstract "Triple-negative breast cancer (TNBC) represents an aggressive subtype with limited therapeutic options. Experimental preclinical models that recapitulate their tumors of origin can accelerate target identification, thereby potentially improving therapeutic efficacy. Patient-derived xenografts (PDXs), due to their genomic and transcriptomic fidelity to the tumors from which they are derived, are poised to improve the preclinical testing of drug-target combinations in translational models. Despite the previous development of breast and TNBC PDX models, those derived from patients with demonstrated health-disparities are lacking. We use an aggressive TNBC PDX model propagated in SCID/Beige mice that was established from an African-American woman, TU-BcX-2 K1, and assess its metastatic potential and drug sensitivities under distinct in vitro conditions. Cellular derivatives of the primary tumor or the PDX were grown in 2D culture conditions or grown in mammospheres 3D culture. Flow cytometry and fluorescence staining was used to quantify cancer stem cell-like populations. qRT-PCR was used to describe the mesenchymal gene signature of the tumor. The sensitivity of TU-BcX-2 K1-derived cells to anti-neoplastic oncology drugs was compared in adherent cells and mammospheres. Drug response was evaluated using a live/dead staining kit and crystal violet staining. TU-BcX-2 K1 has a low propensity for metastasis, reflects a mesenchymal state, and contains a large burden of cancer stem cells. We show that TU-BcX-2 K1 cells have differential responses to cytotoxic and targeted therapies in 2D compared to 3D culture conditions insofar as several drug classes conferred sensitivity in 2D but not in 3D culture, or cells grown as mammospheres. Here we introduce a new TNBC PDX model and demonstrate the differences in evaluating drug sensitivity in adherent cells compared to mammosphere, or suspension, culture." @default.
• W2938221794 created "2019-04-25" @default.
• W2938221794 creator A5006697336 @default.
• W2938221794 creator A5009651508 @default.
• W2938221794 creator A5010254355 @default.
• W2938221794 creator A5010293836 @default.
• W2938221794 creator A5014408610 @default.
• W2938221794 creator A5018126063 @default.
• W2938221794 creator A5036869902 @default.
• W2938221794 creator A5041222618 @default.
• W2938221794 creator A5041301571 @default.
• W2938221794 creator A5048983251 @default.
• W2938221794 creator A5056749846 @default.
• W2938221794 creator A5058795691 @default.
• W2938221794 creator A5063837076 @default.
• W2938221794 creator A5081860821 @default.
• W2938221794 creator A5082016732 @default.
• W2938221794 creator A5083470640 @default.
• W2938221794 creator A5085120914 @default.
• W2938221794 creator A5089006643 @default.
• W2938221794 date "2019-03-07" @default.
• W2938221794 modified "2023-10-14" @default.
• W2938221794 title "Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model" @default.
• W2938221794 cites W1656241491 @default.
• W2938221794 cites W1981421409 @default.
• W2938221794 cites W1989854110 @default.
• W2938221794 cites W2024229755 @default.
• W2938221794 cites W2026548544 @default.
• W2938221794 cites W2035131746 @default.
• W2938221794 cites W2037834319 @default.
• W2938221794 cites W2039165130 @default.
• W2938221794 cites W2044406093 @default.
• W2938221794 cites W2044722516 @default.
• W2938221794 cites W2054034979 @default.
• W2938221794 cites W2056229778 @default.
• W2938221794 cites W2058928888 @default.
• W2938221794 cites W2091336659 @default.
• W2938221794 cites W2113247673 @default.
• W2938221794 cites W2118952409 @default.
• W2938221794 cites W2124323004 @default.
• W2938221794 cites W2125094267 @default.
• W2938221794 cites W2127216239 @default.
• W2938221794 cites W2127362646 @default.
• W2938221794 cites W2127967682 @default.
• W2938221794 cites W2134539328 @default.
• W2938221794 cites W2144481439 @default.
• W2938221794 cites W2236643502 @default.
• W2938221794 cites W2308070604 @default.
• W2938221794 cites W2516260138 @default.
• W2938221794 cites W2521953092 @default.
• W2938221794 cites W2535352967 @default.
• W2938221794 cites W2564066883 @default.
• W2938221794 cites W2565873626 @default.
• W2938221794 cites W2607618862 @default.
• W2938221794 cites W2608811728 @default.
• W2938221794 cites W2612901302 @default.
• W2938221794 cites W2627051037 @default.
• W2938221794 cites W2756148605 @default.
• W2938221794 cites W2757067487 @default.
• W2938221794 cites W2770078888 @default.
• W2938221794 cites W2791981903 @default.
• W2938221794 doi "https://doi.org/10.1186/s12885-019-5401-2" @default.
• W2938221794 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6407287" @default.
• W2938221794 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30845999" @default.
• W2938221794 hasPublicationYear "2019" @default.
• W2938221794 type Work @default.
• W2938221794 sameAs 2938221794 @default.
• W2938221794 citedByCount "17" @default.
• W2938221794 countsByYear W29382217942019 @default.
• W2938221794 countsByYear W29382217942020 @default.
• W2938221794 countsByYear W29382217942021 @default.
• W2938221794 countsByYear W29382217942022 @default.
• W2938221794 countsByYear W29382217942023 @default.
• W2938221794 crossrefType "journal-article" @default.
• W2938221794 hasAuthorship W2938221794A5006697336 @default.
• W2938221794 hasAuthorship W2938221794A5009651508 @default.
• W2938221794 hasAuthorship W2938221794A5010254355 @default.
• W2938221794 hasAuthorship W2938221794A5010293836 @default.
• W2938221794 hasAuthorship W2938221794A5014408610 @default.
• W2938221794 hasAuthorship W2938221794A5018126063 @default.
• W2938221794 hasAuthorship W2938221794A5036869902 @default.
• W2938221794 hasAuthorship W2938221794A5041222618 @default.
• W2938221794 hasAuthorship W2938221794A5041301571 @default.
• W2938221794 hasAuthorship W2938221794A5048983251 @default.
• W2938221794 hasAuthorship W2938221794A5056749846 @default.
• W2938221794 hasAuthorship W2938221794A5058795691 @default.
• W2938221794 hasAuthorship W2938221794A5063837076 @default.
• W2938221794 hasAuthorship W2938221794A5081860821 @default.
• W2938221794 hasAuthorship W2938221794A5082016732 @default.
• W2938221794 hasAuthorship W2938221794A5083470640 @default.
• W2938221794 hasAuthorship W2938221794A5085120914 @default.
• W2938221794 hasAuthorship W2938221794A5089006643 @default.
• W2938221794 hasBestOaLocation W29382217941 @default.
• W2938221794 hasConcept C121608353 @default.
• W2938221794 hasConcept C126322002 @default.
• W2938221794 hasConcept C142724271 @default.
• W2938221794 hasConcept C143998085 @default.
• W2938221794 hasConcept C198826908 @default.
• W2938221794 hasConcept C2779013556 @default.
• W2938221794 hasConcept C2780110267 @default.

• next